乳腺癌临床试验中男性患者的排除 - Suppr

Exclusion of Male Patients in Breast Cancer Clinical Trials.

作者信息

Duma Narjust, Hoversten Katherine P, Ruddy Kathryn J

机构信息

Medical Oncology, Mayo Clinic, Rochester, MN.

Internal Medicine, Mayo Clinic, Rochester, MN.

出版信息

JNCI Cancer Spectr. 2018 Jun 1;2(2):pky018. doi: 10.1093/jncics/pky018. eCollection 2018 Apr.

DOI:10.1093/jncics/pky018

PMID:31360850

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6649834/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7a/6649834/d56900939469/pky018f1.jpg

相似文献

Exclusion of Male Patients in Breast Cancer Clinical Trials.

JNCI Cancer Spectr. 2018 Jun 1;2(2):pky018. doi: 10.1093/jncics/pky018. eCollection 2018 Apr.

Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.

Oral Oncol. 2019 Mar;90:23-29. doi: 10.1016/j.oraloncology.2019.01.023. Epub 2019 Feb 1.

Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancer.

J Cancer Res Clin Oncol. 2019 Dec;145(12):3099-3104. doi: 10.1007/s00432-019-03034-7. Epub 2019 Sep 23.

Screening for breast cancer with mammography.

Cochrane Database Syst Rev. 2001(4):CD001877. doi: 10.1002/14651858.CD001877.

Tamoxifen for early breast cancer.

Cochrane Database Syst Rev. 2001(1):CD000486. doi: 10.1002/14651858.CD000486.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Lancet. 1998 May 16;351(9114):1451-67.

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.

Oncologist. 2019 Jan;24(1):96-102. doi: 10.1634/theoncologist.2017-0687. Epub 2018 Nov 9.

Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus.

J Am Geriatr Soc. 2013 May;61(5):734-8. doi: 10.1111/jgs.12215. Epub 2013 Apr 16.

Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

JAMA Netw Open. 2020 Oct 1;3(10):e2020312. doi: 10.1001/jamanetworkopen.2020.20312.

Accuracy of an Artificial Intelligence System for Cancer Clinical Trial Eligibility Screening: Retrospective Pilot Study.

JMIR Med Inform. 2021 Mar 26;9(3):e27767. doi: 10.2196/27767.

引用本文的文献

Male Breast Cancer: Evaluating the Current Landscape of Diagnosis and Treatment.

Breast Cancer (Dove Med Press). 2025 Jul 5;17:567-572. doi: 10.2147/BCTT.S516124. eCollection 2025.

Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer.

Diagn Pathol. 2025 Apr 15;20(1):43. doi: 10.1186/s13000-025-01632-3.

Global, Regional, and National Burden of Male Breast Cancer, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021.

Cancer Med. 2025 Feb;14(3):e70632. doi: 10.1002/cam4.70632.

Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial.

Oncologist. 2024 Oct 30. doi: 10.1093/oncolo/oyae291.

Breast Cancer in a Filipino Male: A Case Report and Brief Literature Review.

Acta Med Philipp. 2024 Feb 28;58(3):70-75. doi: 10.47895/amp.vi0.6742. eCollection 2024.

Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.

BMC Geriatr. 2024 Mar 25;24(1):282. doi: 10.1186/s12877-024-04861-1.

Male ductal carcinoma in situ: diagnosis and management of a rare disease in men.

BMJ Case Rep. 2024 Mar 18;17(3):e256608. doi: 10.1136/bcr-2023-256608.

Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship.

Curr Oncol Rep. 2024 Jan;26(1):34-45. doi: 10.1007/s11912-023-01489-z. Epub 2024 Jan 2.

Revisiting Exclusion of Prior Cancer in Clinical Trials of Male Breast Cancer.

J Cancer. 2023 Mar 21;14(5):737-740. doi: 10.7150/jca.80740. eCollection 2023.

Male triple negative axillary accessory breast cancer-a case report.

Transl Cancer Res. 2022 Aug;11(8):2926-2930. doi: 10.21037/tcr-22-33.

本文引用的文献

Cancer statistics, 2018.

CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Br J Cancer. 2013 Jun 11;108(11):2259-63. doi: 10.1038/bjc.2013.255. Epub 2013 May 30.

Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983-2009.

Ann Surg Oncol. 2013 May;20(5):1545-50. doi: 10.1245/s10434-013-2918-5. Epub 2013 Mar 5.

Strategies to improve recruitment to randomised controlled trials.

Cochrane Database Syst Rev. 2010 Jan 20(1):MR000013. doi: 10.1002/14651858.MR000013.pub4.

Leuprolide acetate plus aromatase inhibition for male breast cancer.

J Clin Oncol. 2006 Jul 20;24(21):e42-3. doi: 10.1200/JCO.2006.07.2397.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Exclusion of Male Patients in Breast Cancer Clinical Trials.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献